Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake

By Endrikat J.   Gerlinger C.   Cronin M.   Wessel J.   Ruebig A.   Rosenbaum P.   Düsterberg B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 4, 2001-12 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite

Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene

By Endrikat J.   Gerlinger C.   Cronin M.   Ruebig A.   Schmidt W.   Düsterberg B.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 3, 2001-09 ,pp. : 159-166

Informa Healthcare

Access to resources Recommend Favorite

A randomized, controlled trial of a low-dose contraceptive containing 20 g of ethinyl estradiol and 100 g of levonorgestrel for acne treatment

By Thiboutot D.   Archer D.F.   Lemay A.   Washenik K.   Roberts J.   Harrison D.D.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 461-468

Elsevier

Access to resources Recommend Favorite

Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 g or 30 g) and levonorgestrel (100 g or 150 g) on lipoprotein metabolism

By Scharnagl H.   Petersen G.   Nauck M.   Teichmann A.T.   Wieland H.   Marz W.  

Contraception, Vol. 69, Iss. 2, 2004-02 ,pp. : 105-113

Elsevier

Access to resources Recommend Favorite

No benefit, but increased harm from high dose (100 μg) misoprostol for induction of labour: a randomised trial of high vs. low (50 μg) dose misoprostol

By Majoko F.   Nystrom L.   Lindmark G.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 6, 2002-11 ,pp. : 614-617

Informa Healthcare

Access to resources Recommend Favorite